Tsvetan Genkov

Recent publications · Crossref

5 total works indexed

1. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

   · 2019 · cited 2,777x

2. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

   · 2019 · cited 2,530x

3. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors

   · 2021 · cited 623x

4. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

   · 2019 · cited 509x

5. Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

   · 2019 · cited 334x

via Crossref · CC0